Markers of inflammation used in clinical practice to monitor sepsis syndrome, such as C-reactive protein, procalcitonin, and D-dimer, were elevated in 557/576 (96.7%), 413/576 (71.7%), and 469/476 (98.5%) of participants, respectively, and were significantly higher in those who died (Table 2). This evidence concerns the gene CRP and systemic inflammatory response syndrome.